about
Sub-Tenon's anaesthesia versus topical anaesthesia for cataract surgeryThe legibility of prescription medication labelling in Canada: Moving from pharmacy-centred to patient-centred labelsSymptom burden in persons with spinal cord injury.Intravitreal crystalline drug delivery for intraocular proliferation diseases.ClereMed: Lessons Learned From a Pilot Study of a Mobile Screening Tool to Identify and Support Adults Who Have Difficulty With Medication Labels.Prevalence and causes of visual impairment among Saudi adults attending primary health care centers in northern Saudi Arabia.Phakic intraocular lenses for the treatment of refractive errors: an evidence-based analysis.Gut microbiota influences pathological angiogenesis in obesity-driven choroidal neovascularization.Prevalence and causes of blindness and low vision in khuzestan province, iran.Better Visual Outcome by Intraocular Lens Ejection in Geriatric Patients with Ruptured Ocular InjuriesImproving the legibility of prescription medication labels for older adults and adults with visual impairment.Prevalences and causes of vision impairment in elderly Chinese: a socioeconomic perspective of a comparative report nested in Jiangsu Eye StudyDeficiency in the metabolite receptor SUCNR1 (GPR91) leads to outer retinal lesions.Evaluation of peripheral fundus autofluorescence in eyes with wet age-related macular degeneration.Prevalence and causes of visual impairment among Saudi adults.Factors Associated With Visual Impairment and Eye Care Utilization: The International Mobility in Aging Study.Conjunctiva derived mesenchymal stem cell (CJMSCs) as a potential platform for differentiation into corneal epithelial cells on bioengineered electrospun scaffolds.Gene expression levels of the insulin-like growth factor family in patients with AMD before and after ranibizumab intravitreal injections.Prevalence, Causes and Social Factors of Visual Impairment among Chinese Adults: Based on a National Survey.A comparative study of complications of cataract surgery with phacoemulsification in eyes with high and normal axial length.Prostate-specific membrane antigen is undetectable in choroidal neovascular membrane.Prevalence and factors associated with childhood visual impairment in Ethiopia.Prevalence of vision loss among hospital in-patients; a risk factor for falls?Visual impairment and risk of depression: A longitudinal follow-up study using a national sample cohort.Prevalence and causes of low vision and blindness in an elderly population in Nepal: the Bhaktapur retina study.Quantification of retinal changes after resolution of submacular hemorrhage secondary to polypoidal choroidal vasculopathy.The effects of blurred vision on auditory-visual speech perception in younger and older adults.Prevalence and risk factors of visual impairment and blindness in Korea: the Fourth Korea National Health and Nutrition Examination Survey in 2008-2010.Screening for impaired vision in community-dwelling adults aged 65 years and older in primary care settings.Causes of Permanent Severe Visual Impairment and Blindness among Jordanian Population.Effect of Timing of Initial Cataract Surgery, Compliance to Amblyopia Therapy on Outcomes of Secondary Intraocular Lens Implantation in Chinese Children: A Retrospective Case Series.Visual impairment and blindness in a population-based study of Mashhad, Iran.
P2860
Q24187745-088E2C56-DE54-4F4A-8B3B-CF5B15C2AD05Q33630649-D6B101B0-1524-4595-91A4-1C3EDD9BB608Q33827604-F5E99B20-92B4-47E5-9CE0-3EE6CB9621F9Q33847455-78737D16-3BD3-4161-A9D5-53055B6A2506Q34102373-BFB89CD2-CBA3-4515-8BCE-98CCDADA6513Q35245486-3994FE65-1A8D-4653-AEC7-A378D8C56D9EQ36040026-5471C8A9-B9F0-462B-A9B8-BB661AED48EBQ36196897-A085721C-5505-403D-B479-34698B1B4EC6Q36251352-16338972-7FC3-4C1D-A624-AECBD1A870C6Q36255801-01FBD9EB-636E-4BB6-B703-28ABF29466AEQ36882429-EE842C59-766B-4933-AC90-F53E80616866Q37110829-9839B5A0-1692-45C5-9B10-830647FC7526Q37320556-5E68D523-8A71-42C1-B566-4BC47714438DQ37515638-F9CE4234-8B80-42B4-9BB6-034A79E148A0Q37723565-04FEACAA-D96E-44B2-B541-53657BC76883Q38711703-EB6F7DCD-6110-46FB-A0E9-58D6A9B515A8Q38757224-54F6A833-C64A-4419-8A34-40DD59C0FE72Q41382285-423075F5-8A4F-4DEC-B6C3-E12A54171E4DQ41659738-81CC5AAC-D75E-4A74-9D9C-437D66F5A314Q42717486-9910EAC1-2F87-487D-BB87-9606D2B9184CQ43101704-2EB87EDE-E2D4-4162-A681-CB575CAE01FEQ47095398-3AFA768A-415B-4593-801C-9B706F52C9A0Q47561783-56252F4C-CED7-4529-9123-36740596E1D1Q47639165-BFD4FB31-6994-4140-9C75-A6400C5533C1Q49432901-EF644B12-0202-428D-A7AE-2FAEF9BAEB12Q49502188-81744728-E3EC-4FFA-A080-C1DBE5BBA357Q51899113-E8050A7E-E26F-478A-A0E5-E8BCEF6D1D27Q53095957-5A36DA87-0775-4CE3-8251-71366D5411E7Q55010981-26C76817-CFAE-435D-98B4-EA4FD01499BFQ55069279-D7CB2F70-0B5C-45FF-BF92-FF8925C7D6C9Q55256219-BD296231-BA8F-47DC-8DD7-01AECD9E7F03Q55481376-1081BDAA-0BDB-4BB0-9D6B-D23067EF37D6
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
The prevalence of low vision and blindness in Canada.
@ast
The prevalence of low vision and blindness in Canada.
@en
The prevalence of low vision and blindness in Canada.
@nl
type
label
The prevalence of low vision and blindness in Canada.
@ast
The prevalence of low vision and blindness in Canada.
@en
The prevalence of low vision and blindness in Canada.
@nl
prefLabel
The prevalence of low vision and blindness in Canada.
@ast
The prevalence of low vision and blindness in Canada.
@en
The prevalence of low vision and blindness in Canada.
@nl
P2093
P2860
P356
P1433
P1476
The prevalence of low vision and blindness in Canada.
@en
P2093
Hollands H
Maberley DA
Veselinovic A
Witzigmann M
P2860
P2888
P304
P356
10.1038/SJ.EYE.6701879
P577
2006-03-01T00:00:00Z
P5875
P6179
1018869580